Oxiceutics

Oxiceutics is a microbiome-focused wellness and nutricosmetics company founded by cardiologist and author Dr. William Davis. Operating under the parent company Realize Therapeutics Corp, Oxiceutics develops science-based dietary supplements designed to restore keystone microbial species lost in modern populations. Its flagship products, including Gut to Glow and MyReuteri, utilize proprietary strains like LRDR Lactobacillus reuteri to support the gut-skin axis, improve skin appearance, and enhance overall metabolic health. The company also maintains a research pipeline targeting conditions such as small intestinal bacterial overgrowth (SIBO), metabolic endotoxemia, and genitourinary syndrome.